It is the first step that mainly determines the selection of correct branch sites, consistent with the fact that all SUGP1 cancer-associated mutations (as well as additional mutations described in this study) partially recapitulate the mutant SF3B1 missplicing pattern (Liu et al. 2020; Alsafadi et al. 2021). Here, SF3B1 is linked to cancer.